Citadel Advisors - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$54,000
-30.8%
232,528
+5.9%
0.00%
Q4 2021$78,000
-79.1%
219,505
-64.7%
0.00%
Q3 2021$374,000
-51.8%
622,178
+2.6%
0.00%
Q1 2021$776,000
+1058.2%
606,189
+665.5%
0.00%
Q3 2020$67,000
-75.2%
79,192
-82.1%
0.00%
Q2 2020$270,000
+350.0%
442,811
+427.3%
0.00%
Q1 2020$60,00083,9700.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2022
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 432,503$554,0000.09%
MONECO Advisors, LLC 35,000$45,0000.02%
Purus Wealth Management, LLC 15,000$19,0000.02%
Renaissance Technologies 8,454,364$10,822,0000.01%
LMR Partners LLP 390,864$500,0000.01%
ExodusPoint Capital Management, LP 595,459$762,0000.01%
LINCOLN CAPITAL CORP 12,000$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 264,500$339,0000.01%
HRT FINANCIAL LP 347,816$445,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 25,000$32,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders